Evidence map›Paper›PMID 25662104›Full record

SynthesisBiological psychiatry2015

Neurobiological impact of nicotinic acetylcholine receptor agonists: an activation likelihood estimation meta-analysis of pharmacologic neuroimaging studies.

Matthew T Sutherland, Kimberly L Ray, Michael C Riedel, Julio A Yanes, Elliot A Stein, Angela R Laird

3 registry-linked trialsAbstract readMeta-Analysis
In one paragraph

Synthesis in Biological psychiatry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04433767 phase2completednot on this mapstarted 2020, after this paper: background citation

Nicotinic Modulation of the Cognitive Control System in Late-life Depression

TypeinterventionalSponsorVanderbilt University Medical CenterRan2020 to 2022Enrolled29ConditionsDepressive DisorderArmsTransdermal Nicotine patch
NCT05746273 phase2completednot on this mapstarted 2023, after this paper: background citation

Nicotinic Modulation of the Cognitive Control System in Late-Life Depression (R33 Phase)

TypeinterventionalSponsorVanderbilt University Medical CenterRan2023 to 2026Enrolled40ConditionsDepressive DisorderArmsTransdermal Nicotine Patch, Transdermal Placebo Patch
NCT05746546 phase2completednot on this mapstarted 2023, after this paper: background citation

Open Label Extension Study of Depressed Mood Improvement Through Nicotine (Depressed MIND3)

TypeinterventionalSponsorVanderbilt University Medical CenterRan2023 to 2026Enrolled25ConditionsDepressive DisorderArmsTransdermal Nicotine patch
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Short-term nicotine deprivation alters dorsal anterior cingulate glutamate concentration and concomitant cingulate-cortical functional connectivity.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2020
    Trial
  4. Nicotine normalizes cortico-striatal connectivity in non-smoking individuals with major depressive disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Neuroimaging Biomarkers in Addiction.medRxiv : the preprint server for health sciences · 2024
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Association of PolymorphismInternational journal of environmental research and public health · 2022
    Article
  15. Article
  16. Review
  17. Review
  18. Low Smoking Exposure, the Adolescent Brain, and the Modulating Role of CHRNA5 Polymorphisms.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2019
    Article
  19. Oral Contraceptives and Cigarette Smoking: A Review of the Literature and Future Directions.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Matthew T SutherlandDepartment of Psychology, Florida International University, Miami, Florida. Electronic address: masuther@fiu.edu.
Kimberly L RayDepartment of Psychiatry, University of California, Davis, Sacramento, California.
Michael C RiedelResearch Imaging Institute, University of Texas Health Science Center, San Antonio, Texas.
Julio A YanesDepartment of Physics, Florida International University, Miami, Florida.
Elliot A SteinNeuroimaging Research Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health/Department of Health and Human Services, Baltimore, Maryland.
Angela R LairdDepartment of Physics, Florida International University, Miami, Florida.
Florida International University · USNational Institute on Drug Abuse · USThe University of Texas Health Science Center at San Antonio · USUniversity of California, Davis · US

Funding

Functional and Structural Brain Circuits Underlying SmokingZIADA000573 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI STEIN, ELLIOT A · 2010 to 2021
$19.4M
Meta-anaylsis in human brain mappingR01MH074457 · NIMH · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI FOX, PETER THORNTON · 2006 to 2024
$10.5M
BrainMap Tracker: Automated Annotation of Brain Mapping ExperimentsR56MH097870 · NIMH · THE MIND RESEARCH NETWORK · PI LAIRD, ANGELA R, TURNER, JESS · 2012 to 2013
$1.1M
Impact of HIV and cannabis on brain function: Regions, networks, and the connectoK01DA037819 · NIDA · FLORIDA INTERNATIONAL UNIVERSITY · PI SUTHERLAND, MATTHEW T · 2014 to 2018
$784k
Intramural NIH HHSNIDA NIH HHS K01 DA037819NIDA NIH HHS K01-DA037819NIMH NIH HHS R01 MH074457NIMH NIH HHS R01-MH074457NIMH NIH HHS R56 MH097870NIMH NIH HHS R56-MH097870
6 · The paper itself

Abstract

backgroundNicotinic acetylcholine receptor (nAChR) agonists augment cognition among cigarette smokers and nonsmokers, yet the systems-level neurobiological mechanisms underlying such improvements are not fully understood. Aggregating neuroimaging results regarding nAChR agonists provides a means to identify common functional brain changes that may be related to procognitive drug effects.

methodsWe conducted a meta-analysis of pharmacologic neuroimaging studies within the activation likelihood estimation framework. We identified published studies contrasting a nAChR drug condition versus a baseline and coded each contrast by activity change direction (decrease or increase), participant characteristics (smokers or nonsmokers), and drug manipulation employed (pharmacologic administration or cigarette smoking).

resultsWhen considering all studies, nAChR agonist administration was associated with activity decreases in multiple regions, including the ventromedial prefrontal cortex (vmPFC), posterior cingulate cortex (PCC), parahippocampus, insula, and the parietal and precentral cortices. Conversely, activity increases were observed in lateral frontoparietal cortices, the anterior cingulate cortex, thalamus, and cuneus. Exploratory analyses indicated that both smokers and nonsmokers showed activity decreases in the vmPFC and PCC, and increases in lateral frontoparietal regions. Among smokers, both pharmacologic administration and cigarette smoking were associated with activity decreases in the vmPFC, PCC, and insula and increases in the lateral PFC, dorsal anterior cingulate cortex, thalamus, and cuneus.

conclusionsThese results provide support for the systems-level perspective that nAChR agonists suppress activity in default-mode network regions and enhance activity in executive control network regions in addition to reducing activation of some task-related regions. We speculate these are potential mechanisms by which nAChR agonists enhance cognition.

Indexed as

BrainBrain MappingHumansLikelihood FunctionsMagnetic Resonance ImagingNicotinic AgonistsPositron-Emission TomographyReceptors, NicotinicSmokingNicotinic AgonistsReceptors, NicotinicActivation likelihood estimation (ALE)Default mode network (DMN)Executive control network (ECN)NicotinePharmacologic functional magnetic resonance imaging (fMRI)Withdrawal

Identifiers

PMID25662104
PMCPMC4494985
OpenAlexW1991656721

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.